Home / Anti-infectives / Piperacillin and Beta-Lactamase Inhibitor
ATC J01CR05 · Antibacterials for Systemic Use
Piperacillin and Beta-Lactamase Inhibitor shortage
As of 31 Oct 2026, Piperacillin and Beta-Lactamase Inhibitor has a reported shortage in 2 of the 5 countries we track (Italy, Belgium), covering 7 products.
Countries2/5
Products7packs or presentations
Short since20 Jul 20233.3 years ago
Earliest return31 Oct 2026company estimate
No return date4products
Main reasonCommercial decision or withdrawal
Timeline
ItalyBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | PIPERACILLINA E TAZOBACTAM AUROBINDO | Eugia Pharma (Malta) Limited | 1 Nov 2024 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale ospedaliero) |
| IT | PIPERACILLINA E TAZOBACTAM KABI | FRESENIUS KABI ITALIA S.R.L. | 13 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | PIPERACILLINA E TAZOBACTAM TEVA | TEVA ITALIA S.R.L. | 31 Jul 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | PIPERACILLINA/TAZOBACTAM TILLOMED | TILLOMED ITALIA SRL | 15 Sep 2026 | 31 Oct 2026 | Increased demand Elevata richiesta |
| IT | PIPERACILLINA E TAZOBACTAM SANDOZ announced | SANDOZ S.P.A. | 1 Dec 2026 | not given | Increased demand Elevata richiesta |
| BE | Piperacillin/Tazobactam Eugia 2 g - 250 mg inf. sol. (pwdr.) i.v. vial 10 (2 g - 250 mg) | Eugia Pharma (Malta) | 20 Jul 2023 | 1 Mar 2027 | Other Other reason |
| BE | Piperacillin/Tazobactam Eugia 4 g - 500 mg inf. sol. (pwdr.) i.v. vial 10 (4 g - 500 mg) | Eugia Pharma (Malta) | 20 Jul 2023 | 1 Mar 2027 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.